Lymphoblastic leukemia in children
Information
- Disease name
- Lymphoblastic leukemia in children
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03595969 | Completed | Association Between Mitochondrial DNA Content and Risk of Acute Leukemia | November 1, 2018 | October 1, 2019 | |
| NCT05038696 | Recruiting | Phase 1 | ALaCART-B: Acute Leukemia and Chimeric Antigen Receptor-T Cell Therapy for B-lymphoblastic Leukemia. | April 28, 2021 | August 1, 2026 |
| NCT05043571 | Recruiting | Phase 1 | CARTALL: Chimeric-Antigen Receptor (CAR) T-Cell Therapy for Relapsed/ Refractory T-Lineage Acute Lymphoblastic Leukaemia | September 8, 2021 | November 1, 2026 |
| NCT05429905 | Recruiting | Phase 1/Phase 2 | Dual Anti-CD22/CD19 Chimeric Antigen Receptor-directed T Cells (CART2219.1) for Relapsed Refractory B-Lineage Leukaemia | July 18, 2022 | December 2025 |
| NCT05648019 | Recruiting | Phase 2 | CD19-Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory B-Lineage Leukaemia / Lymphoma - A Feasibility Protocol | March 15, 2022 | December 2026 |
| NCT06099366 | Recruiting | Phase 2 | Treatment of Newly Diagnosed Standard Risk Acute Lymphoblastic Leukemia in Children | March 5, 2024 | December 31, 2033 |